2022 Feline Health Grants
January 24, 2023 (published)
EveryCat Health Foundation

EveryCat Health Foundation
2022 Feline Health Grants
11 Grants Funded for a Total of $294,186

Forty cat health grant proposals were submitted for the 2022 EveryCat Health Foundation Grant cycle. After a rigorous review by scientific advisors, board members, and a statistician, 11 proposals were recommended for funding by the Foundation’s Grant Review Committee. Awards for this year’s grant cycle totaled just over $294,000.00 USD.

Proposals were submitted from all over the world, encompassing a distinct range of feline health topics, including novel diagnostic and treatment investigations for feline infectious peritonitis, chronic kidney disease biomarkers, and cardiovascular disease treatment therapies.

Past highlights from EveryCat Health Foundation funding include the discovery of taurine as the major cause of dilated cardiomyopathy, the use of high protein/low carbohydrate diets as the mainstay treatment of diabetes mellitus, discovery of feline blood types, development of in-clinic Feline Leukemia tests, treatment of asthma with metered-dose inhalant therapy, effective antiviral therapy for FIP, and many, many other accomplishments.

EveryCat Health Foundation’s collaborative work is made possible through the generosity of sponsors and donors. “We fund innovative health studies that advance veterinary knowledge and expertise. As the world’s only nonprofit foundation committed solely to supporting cat health research—EveryCat Health Foundation helps your cat, my cat, community cats—all cats, everywhere,” Jackie Ott Jaakola, Executive Director, EveryCat Health Foundation.

EveryCat Health Foundation awarded grants for the following research studies:

General Studies

Is platelet Toll-like receptor 4 the silent partner of thrombosis in cats with hypertrophic cardiomyopathy? $32,017 
Investigating the immunothrombotic interactions between histones and platelets. 
Principal lnvestigator(s): Drs. Ronald Hok Long Li, Wan Khoon Avalene Tan, and Joshua A. Stern, University of California Davis, School of Veterinary Medicine. (EC22-002)

Characterization and causative investigation of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia. $9,026
Principal lnvestigator(s): Drs. Victoria Watson and Jared Jaffey; Midwestern University. (EC22-018)

The obesity-microbiome connection - determine gut flora signatures of obese cat. $34,583
Principal lnvestigator(s): Xu Wang; Auburn University College of Veterinary Medicine. (EC22-023)

Unraveling the blood bacterial microbiome in healthy and febrile domestic cats via 16S rRNA metagenomics. $32,000
Principal lnvestigator(s): Drs. Ananda Muller and Katrin Hartmann; Ludwig-Maximilians-Universitat Munchen. (EC22-028)

Dexmedetomidine-vatinoxan-ketamine for anesthesia in cats. $35,000
Principal lnvestigator(s): Bruno Pypendop, Linda Barter; University of California-Davis EC22-038

Feline Kidney Disease Fund in honor of Dr. Vicki Thayer-Board Designated Match (Sponsored by Zoetis)

Effect of EPA and DHA supplementation on renal function biomarkers and systolic blood pressure of proteinuric and borderline proteinuric cats diagnosed with chronic kidney disease. $33,942
Principal lnvestigator(s): Drs. Ana Luisa Guimaraes Dias Lourenc and Tomas Rodrigues Magalhaes; University of Tras-os-Montes and Alto Douro, Portugal. (EC22-015)

Ricky Fund Study

Thromboelastography in cats with hypertrophic cardiomyopathy." $31,297
Principal lnvestigator(s): Drs. Giulio Menciotti and Ashley Wilkinson; Virginia-Maryland College of Veterinary Medicine, Virginia Tech. (EC22-003)

Testing for Clopidogrel Resistance in Cats Presenting to First Opinion Practices." $13,867
Principal lnvestigator(s): Anthony Abrams-Ogg and Matthew Kornya; Ontario Veterinary College, University of Guelph. (EC22-005)

Bria Fund Study

Acute phase protein and micro-RNA signatures for the diagnosis and prognosis of feline infectious peritonitis." $7,500
Principal lnvestigator(s): Professor Danielle Gunn­ Moore; Royal (Dick) School of Veterinary Studies and The Roslin Institute, The University of Edinburgh. (EC22-005)

EIDD-2801 (Molnupiravir): establishing an oral dose and evidence for efficacy in cats with FIP.  $33,550
Principal lnvestigator(s): Brian Murphy and Krystle Reagan; School of Veterinary Medicine, University of California, Davis. (EC22-007)

EveryCat Health Foundation & Cancer/Oncology Fund (Sponsored by IDEXX)

Comprehensive mutational profiling of the oncogenomic landscape of commonly-occurring cancers in domestic cats to pave the way for precision veterinary medicine and understanding cancer biology. $31,426.79  ($28,296.79 EveryCat Health Foundation, $3,730.00 Cancer/Oncology Fund)
Principal lnvestigator(s): Drs. Louise van der Weyden and David Adams; Wellcome Sanger Institute, Cambridge, United Kingdom. (EC22-021)